French Senate toughens up comparator trials requirements: devices within scope
This article was originally published in Clinica
Executive Summary
The French Senate has approved the bill on reforming the healthcare product regulatory system, together with an amendment that would lead to medical devices soon becoming subject to requirements for clinical trials against the gold standard therapy. This tough new measure is expected to first be applied to pharmaceuticals.